/TRLS.L
TRLS.L Stock - Trellus Health plc
Healthcare|Medical - Healthcare Information ServicesLSE
$0.55+0.00%
+$0.00 (+0.00%) • Dec 22
43
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.5
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.37
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.61
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for TRLS.L
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.54 – $0.56
TARGET (TP)$0.63
STOP LOSS$0.51
RISK/REWARD1:2.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta2.09
52W High$5.40
52W Low$0.33
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $114,000 | $19,000 | $18,000 | $25,000 | N/A |
| Gross Profit | $114,000 | $19,000 | $18,000 | $25,000 | N/A |
| Gross Margin | 100.0% | 100.0% | 100.0% | 100.0% | N/A |
| Operating Income | $-8,027,000 | $-6,803,000 | $-8,810,000 | $-5,902,000 | $-1,524,000 |
| Net Income | $-7,782,000 | $-6,339,000 | $-8,810,000 | $-5,902,000 | $-1,524,000 |
| Net Margin | -6826.3% | -33363.2% | -48944.4% | -23608.0% | N/A |
| EPS | $-0.05 | $-0.04 | $-0.05 | $-0.04 | $-0.02 |
Company Overview
Trellus Health plc provides digital chronic condition management solutions for employers and health plans. The company offers TrellusElevate, a proprietary HIPAA-compliant technology platform to coordinate and deliver personalized care remotely through telemedicine. Its platform provides patients with access to a care team, educational content resources, and remote monitoring capabilities for the treatment of inflammatory bowel diseases, which include the chronic incurable conditions of Crohn's Disease and ulcerative colitis. The company was founded in 2020 and is headquartered in White Plains, New York.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
TRLS.LBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.02
Q3 2024
EPS Surprise History
Q2 21
No data
Q3 21
No data
Q2 22
No data
Q3 22
No data
Q2 23
No data
Q3 23
No data
Q2 24
No data
Q3 24
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Jun 1, 2026 | — | — | — | — |
Q2 2025 | Jun 4, 2025 | — | — | — | — |
Q2 2025 | May 29, 2025 | — | — | — | — |
Q3 2024 | Sep 26, 2024 | — | $-0.02 | — | — |
Q2 2024 | Apr 23, 2024 | — | $-0.01 | — | — |
Q3 2023 | Sep 28, 2023 | — | $-0.02 | — | — |
Q2 2023 | May 23, 2023 | — | $-0.02 | — | — |
Q3 2022 | Sep 30, 2022 | — | $-0.02 | — | — |
Q2 2022 | May 10, 2022 | — | $-0.02 | — | — |
Q3 2021 | Sep 22, 2021 | — | $-0.01 | — | — |
Q2 2021 | May 27, 2021 | — | $-0.01 | — | — |
Q2 2020 | Jun 30, 2020 | — | $-0.01 | — | — |
Latest News
Loading news...
Frequently Asked Questions about TRLS.L
What is TRLS.L's current stock price?
Trellus Health plc (TRLS.L) is currently trading at $0.55 per share. The stock has moved +0.00% today.
What is the analyst price target for TRLS.L?
No analyst price targets are currently available for this stock.
What sector is Trellus Health plc in?
Trellus Health plc operates in the Healthcare sector, specifically within the Medical - Healthcare Information Services industry. The company is traded on the LSE exchange.
What is TRLS.L's market cap?
Trellus Health plc has a market capitalization of $0.00 billion, making it a small-cap company.
Does TRLS.L pay dividends?
No, Trellus Health plc does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorBELL.L
Belluscura plc
$0.75
Mkt Cap: $0.3B
EKF.L
EKF Diagnostics Holdings plc
$25.30
Mkt Cap: $11.4B
POLB.L
Poolbeg Pharma PLC
$4.00
Mkt Cap: $2.8B
RENX.L
Renalytix Plc
$6.25
Mkt Cap: $2.1B
VRCI.L
Verici Dx plc
$0.78
Mkt Cap: $1.2B
Explore stocks similar to TRLS.L for comparison